当前位置:药药网 / 药品研发 / 美国药品上市后承诺数据库
QDOLO (tramadol HCl)
申请企业
ATHENA BIOSCIENCE LLC
药品名称
QDOLO (tramadol HCl)
承诺描述
Conduct a randomized, double-blind, placebo-controlled study evaluating the clinical effectiveness, safety, and pharmacokinetic profiles of QDOLO (tramadol hydrochloride) oral solution in pediatric patients 12 to less than 17 years of age, outside of the contraindicated setting of tonsillectomy and/or adenoidectomy.
承诺状态描述
The study has not been initiated, but it does not meet the criterion for delayed.